{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:04:23Z","timestamp":1784811863199,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmic Physiol. Opt."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s44402-026-00132-1","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T09:34:27Z","timestamp":1782293667000},"page":"914-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Switching Myopia Control Strategies on Axial Elongation in Children with Poor Response to Highly Aspherical Lenslet Therapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Minfeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoquan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"132_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","volume":"123","author":"BA Holden","year":"2016","unstructured":"Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036\u201342. https:\/\/doi.org\/10.1016\/j.ophtha.2016.01.006.","journal-title":"Ophthalmology"},{"key":"132_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","volume":"123","author":"J Huang","year":"2016","unstructured":"Huang J, Wen D, Wang Q, McAlinden C, Flitcroft I, Chen H, et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016;123:697\u2013708. https:\/\/doi.org\/10.1016\/j.ophtha.2015.11.010.","journal-title":"Ophthalmology"},{"key":"132_CR3","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/bjophthalmol-2020-318256","volume":"106","author":"D Tricard","year":"2022","unstructured":"Tricard D, Marillet S, Ingrand P, Bullimore MA, Bourne RRA, Leveziel N. Progression of myopia in children and teenagers: a nationwide longitudinal study. Br J Ophthalmol. 2022;106:1104\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318256.","journal-title":"Br J Ophthalmol"},{"key":"132_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ICL.0000000000000219","volume":"42","author":"YM Liu","year":"2016","unstructured":"Liu YM, Xie P. The safety of orthokeratology\u2014a systematic review. Eye Contact Lens. 2016;42:35\u201342. https:\/\/doi.org\/10.1097\/ICL.0000000000000219.","journal-title":"Eye Contact Lens"},{"key":"132_CR5","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","volume":"113","author":"WH Chua","year":"2006","unstructured":"Chua WH, Balakrishnan V, Chan YH, Tong L, Ling Y, Quah BL, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006;113:2285\u201391. https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.062.","journal-title":"Ophthalmology"},{"key":"132_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Ophthalmology. 2012;119:347\u201354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031.","journal-title":"Ophthalmology"},{"key":"132_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: Myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123:391\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.004.","journal-title":"Ophthalmology"},{"key":"132_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2013.09.020","volume":"157","author":"A Chia","year":"2014","unstructured":"Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451\u2013457.e1. https:\/\/doi.org\/10.1016\/j.ajo.2013.09.020.","journal-title":"Am J Ophthalmol"},{"key":"132_CR9","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1097\/OPX.0000000000000034","volume":"90","author":"J Santodomingo-Rubido","year":"2013","unstructured":"Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Guti\u00e9rrez-Ortega R. Factors preventing myopia progression with orthokeratology correction. Optom Vis Sci. 2013;90:1225\u201336. https:\/\/doi.org\/10.1097\/OPX.0000000000000034.","journal-title":"Optom Vis Sci"},{"key":"132_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10384-018-0573-x","volume":"62","author":"M Na","year":"2018","unstructured":"Na M, Yoo A. The effect of orthokeratology on axial length elongation in children with myopia: contralateral comparison study. Jpn J Ophthalmol. 2018;62:327\u201334. https:\/\/doi.org\/10.1007\/s10384-018-0573-x.","journal-title":"Jpn J Ophthalmol"},{"key":"132_CR11","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53:7077\u201385. https:\/\/doi.org\/10.1167\/iovs.12-10565.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"132_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clae.2020.03.018","volume":"43","author":"MA Bullimore","year":"2020","unstructured":"Bullimore MA, Johnson LA. Overnight orthokeratology. Cont Lens Anterior Eye. 2020;43:322\u201332. https:\/\/doi.org\/10.1016\/j.clae.2020.03.018.","journal-title":"Cont Lens Anterior Eye"},{"key":"132_CR13","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1167\/iovs.11-8453","volume":"53","author":"T Hiraoka","year":"2012","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 2012;53:3913\u20139. https:\/\/doi.org\/10.1167\/iovs.11-8453. Jun 22.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"132_CR14","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/bjophthalmol-2020-318367","volume":"106","author":"J Bao","year":"2022","unstructured":"Bao J, Yang A, Huang Y, Li X, Pan Y, Ding C, et al. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br J Ophthalmol. 2022;106:1171\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318367.","journal-title":"Br J Ophthalmol"},{"key":"132_CR15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140:472\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401.","journal-title":"JAMA Ophthalmol"},{"key":"132_CR16","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","volume":"107","author":"J Rappon","year":"2023","unstructured":"Rappon J, Chung C, Young G, Hunt C, Neitz J, Neitz M, et al. Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS). Br J Ophthalmol. 2023;107:1709\u201315. https:\/\/doi.org\/10.1136\/bjo-2021-321005.","journal-title":"Br J Ophthalmol"},{"key":"132_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2025.102376","volume":"48","author":"Q Liu","year":"2025","unstructured":"Liu Q, Chen Y, Feng Y, Zhang S, Mao X, Xu J. Comparison of two-year myopia control efficacy between spectacle lenses with highly aspherical lenslets and orthokeratology lenses. Cont Lens Anterior Eye. 2025;48:102376. https:\/\/doi.org\/10.1016\/j.clae.2025.102376.","journal-title":"Cont Lens Anterior Eye"},{"key":"132_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.clae.2018.10.026","volume":"42","author":"Z Chen","year":"2019","unstructured":"Chen Z, Chen Z, Huang S, Zhou J, Xiaomei Q, Zhou X, et al. Adjunctive effect of orthokeratology and low dose atropine on axial elongation in fast-progressing myopic children-A preliminary retrospective study. Cont Lens Anterior Eye. 2019;42:439\u201342. https:\/\/doi.org\/10.1016\/j.clae.2018.10.026.","journal-title":"Cont Lens Anterior Eye"},{"key":"132_CR19","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s41433-024-02987-5","volume":"38","author":"T Tang","year":"2024","unstructured":"Tang T, Lu Y, Li X, Zhao H, Wang K, Li Y, et al. Comparison of the long-term effects of atropine in combination with orthokeratology and defocus incorporated multiple segment lenses for myopia control in Chinese children and adolescents. Eye (Lond). 2024;38:1660\u20137. https:\/\/doi.org\/10.1038\/s41433-024-02987-5.","journal-title":"Eye (Lond)"},{"key":"132_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/opo.12834","volume":"41","author":"B Guo","year":"2021","unstructured":"Guo B, Cheung SW, Kojima R, Cho P. One-year results of the Variation of Orthokeratology Lens Treatment Zone (VOLTZ) Study: a prospective randomised clinical trial. Ophthalmic Physiol Opt. 2021;41:702\u201314. https:\/\/doi.org\/10.1111\/opo.12834.","journal-title":"Ophthalmic Physiol Opt"},{"key":"132_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","volume":"237","author":"JC Yam","year":"2022","unstructured":"Yam JC, Jiang Y, Lee J, Li S, Zhang Y, Sun W, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study. Am J Ophthalmol. 2022;237:130\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2021.12.014.","journal-title":"Am J Ophthalmol"},{"key":"132_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang X, Tang SM, Yip BHK, Kam KW, et al. Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: Phase 2 report. Ophthalmology. 2020;127:910\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.011.","journal-title":"Ophthalmology"},{"key":"132_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ophtha.2021.10.016","volume":"129","author":"A Ha","year":"2022","unstructured":"Ha A, Kim SJ, Shim SR, Kim YK, Jung JH. Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis. Ophthalmology. 2022;129:322\u201333. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.016.","journal-title":"Ophthalmology"},{"key":"132_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/OPX.0b013e3182357f79","volume":"89","author":"L Donovan","year":"2012","unstructured":"Donovan L, Sankaridurg P, Ho A, Naduvilath T, Smith EL 3rd, Holden BA. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. 2012;89:27\u201332. https:\/\/doi.org\/10.1097\/OPX.0b013e3182357f79.","journal-title":"Optom Vis Sci"},{"key":"132_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/aos.17496","volume":"103","author":"DC Schmidt","year":"2025","unstructured":"Schmidt DC, Hvid-Hansen A, Jacobsen N, Jakobsen TM, Larsen PM, Lindblad KK, et al. Efficacy of interventions for myopia control in children: a systematic review with network meta-analyses. Acta Ophthalmol. 2025;103:939\u201365. https:\/\/doi.org\/10.1111\/aos.17496.","journal-title":"Acta Ophthalmol"},{"key":"132_CR26","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He M, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, et al. IMI\u2014 defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci. 2019;60:M20\u2013M30. https:\/\/doi.org\/10.1167\/iovs.18-25957.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"132_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaophthalmol.2016.4009","volume":"134","author":"JW Tideman","year":"2016","unstructured":"Tideman JW, Snabel MC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RW, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134:1355\u201363. https:\/\/doi.org\/10.1001\/jamaophthalmol.2016.4009.","journal-title":"JAMA Ophthalmol"},{"key":"132_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/bjophthalmol-2021-319431","volume":"107","author":"X He","year":"2023","unstructured":"He X, Sankaridurg P, Naduvilath T, Wang J, Xiong S, Weng R, et al. Normative data and percentile curves for axial length and axial length\/corneal curvature in Chinese children and adolescents aged 4\u201318 years. Br J Ophthalmol. 2023;107:167\u201375. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319431.","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmic and Physiological Optics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44402-026-00132-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00132-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:51:05Z","timestamp":1784811065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44402-026-00132-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["132"],"URL":"https:\/\/doi.org\/10.1007\/s44402-026-00132-1","relation":{},"ISSN":["0275-5408","1475-1313"],"issn-type":[{"value":"0275-5408","type":"print"},{"value":"1475-1313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by the Wenzhou Medical University Eye Hospital\u2019s Ethics Committee (2025-169-K-139). As this was a retrospective study, the ethics committee agreed that children were not required to provide written informed consent.","order":3,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}